CN113181240A - 构树根皮在制备治疗特应性皮炎的药物上的应用 - Google Patents
构树根皮在制备治疗特应性皮炎的药物上的应用 Download PDFInfo
- Publication number
- CN113181240A CN113181240A CN202110680523.5A CN202110680523A CN113181240A CN 113181240 A CN113181240 A CN 113181240A CN 202110680523 A CN202110680523 A CN 202110680523A CN 113181240 A CN113181240 A CN 113181240A
- Authority
- CN
- China
- Prior art keywords
- group
- nbtoh
- skin
- root bark
- mice
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 206010012438 Dermatitis atopic Diseases 0.000 title claims abstract description 76
- 201000008937 atopic dermatitis Diseases 0.000 title claims abstract description 76
- 239000003814 drug Substances 0.000 title claims abstract description 31
- 238000002360 preparation method Methods 0.000 title claims abstract description 20
- 241000705930 Broussonetia papyrifera Species 0.000 title claims abstract description 12
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims abstract description 29
- 241000933832 Broussonetia Species 0.000 claims abstract description 24
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 11
- 238000000605 extraction Methods 0.000 claims abstract description 10
- 239000000203 mixture Substances 0.000 claims abstract description 10
- 238000009472 formulation Methods 0.000 claims abstract description 4
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 25
- 239000000284 extract Substances 0.000 claims description 15
- 239000002021 butanolic extract Substances 0.000 claims description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 6
- 239000002024 ethyl acetate extract Substances 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 5
- 239000006228 supernatant Substances 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 4
- 239000006185 dispersion Substances 0.000 claims description 3
- 239000012153 distilled water Substances 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims description 3
- 239000002674 ointment Substances 0.000 claims description 3
- 238000002390 rotary evaporation Methods 0.000 claims description 3
- 238000001035 drying Methods 0.000 claims description 2
- 238000001914 filtration Methods 0.000 claims description 2
- 238000010438 heat treatment Methods 0.000 claims description 2
- 239000000047 product Substances 0.000 claims description 2
- 238000010992 reflux Methods 0.000 claims description 2
- 238000005303 weighing Methods 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 239000006071 cream Substances 0.000 claims 1
- 238000001704 evaporation Methods 0.000 claims 1
- 239000007888 film coating Substances 0.000 claims 1
- 238000009501 film coating Methods 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 22
- 229940079593 drug Drugs 0.000 abstract description 13
- 239000000017 hydrogel Substances 0.000 abstract description 13
- 201000010099 disease Diseases 0.000 abstract description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 6
- 239000000499 gel Substances 0.000 abstract description 6
- 239000002994 raw material Substances 0.000 abstract description 3
- 230000014759 maintenance of location Effects 0.000 abstract description 2
- 238000010172 mouse model Methods 0.000 abstract description 2
- 210000003491 skin Anatomy 0.000 description 55
- 241000699670 Mus sp. Species 0.000 description 54
- 238000002474 experimental method Methods 0.000 description 23
- 239000000243 solution Substances 0.000 description 19
- 230000001225 therapeutic effect Effects 0.000 description 19
- 206010015150 Erythema Diseases 0.000 description 14
- 231100000321 erythema Toxicity 0.000 description 14
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 12
- 206010052428 Wound Diseases 0.000 description 10
- 208000027418 Wounds and injury Diseases 0.000 description 10
- 230000000052 comparative effect Effects 0.000 description 10
- 241000699666 Mus <mouse, genus> Species 0.000 description 8
- 208000003251 Pruritus Diseases 0.000 description 7
- 206010030113 Oedema Diseases 0.000 description 6
- 206010039509 Scab Diseases 0.000 description 6
- 238000007490 hematoxylin and eosin (H&E) staining Methods 0.000 description 6
- 201000004624 Dermatitis Diseases 0.000 description 5
- 210000002615 epidermis Anatomy 0.000 description 5
- 230000002757 inflammatory effect Effects 0.000 description 5
- 238000000465 moulding Methods 0.000 description 5
- 238000011160 research Methods 0.000 description 5
- VYZAHLCBVHPDDF-UHFFFAOYSA-N Dinitrochlorobenzene Chemical compound [O-][N+](=O)C1=CC=C(Cl)C([N+]([O-])=O)=C1 VYZAHLCBVHPDDF-UHFFFAOYSA-N 0.000 description 4
- 206010070834 Sensitisation Diseases 0.000 description 4
- 231100000241 scar Toxicity 0.000 description 4
- 230000008313 sensitization Effects 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 208000032544 Cicatrix Diseases 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- 230000001965 increasing effect Effects 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 239000011159 matrix material Substances 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 230000037387 scars Effects 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical group CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- 206010020649 Hyperkeratosis Diseases 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 206010039085 Rhinitis allergic Diseases 0.000 description 2
- 201000009961 allergic asthma Diseases 0.000 description 2
- 201000010105 allergic rhinitis Diseases 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 2
- 229960003957 dexamethasone Drugs 0.000 description 2
- 230000002500 effect on skin Effects 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000003902 lesion Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000037390 scarring Effects 0.000 description 2
- 238000006748 scratching Methods 0.000 description 2
- 230000002393 scratching effect Effects 0.000 description 2
- 208000017520 skin disease Diseases 0.000 description 2
- RMBFBMJGBANMMK-UHFFFAOYSA-N 2,4-dinitrotoluene Chemical group CC1=CC=C([N+]([O-])=O)C=C1[N+]([O-])=O RMBFBMJGBANMMK-UHFFFAOYSA-N 0.000 description 1
- MUKYLHIZBOASDM-UHFFFAOYSA-N 2-[carbamimidoyl(methyl)amino]acetic acid 2,3,4,5,6-pentahydroxyhexanoic acid Chemical compound NC(=N)N(C)CC(O)=O.OCC(O)C(O)C(O)C(O)C(O)=O MUKYLHIZBOASDM-UHFFFAOYSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 238000011725 BALB/c mouse Methods 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 208000001840 Dandruff Diseases 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 208000019028 Epidermal thickening Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 208000001126 Keratosis Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000218231 Moraceae Species 0.000 description 1
- 235000008708 Morus alba Nutrition 0.000 description 1
- 206010033733 Papule Diseases 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 206010040799 Skin atrophy Diseases 0.000 description 1
- 208000028990 Skin injury Diseases 0.000 description 1
- 206010072170 Skin wound Diseases 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 241000819233 Tribulus <sea snail> Species 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 208000030961 allergic reaction Diseases 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 229940124623 antihistamine drug Drugs 0.000 description 1
- 229940125715 antihistaminic agent Drugs 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 229960001631 carbomer Drugs 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 238000009109 curative therapy Methods 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 239000003862 glucocorticoid Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 230000003832 immune regulation Effects 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- 230000037311 normal skin Effects 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 230000008591 skin barrier function Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 229940126585 therapeutic drug Drugs 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 229940047183 tribulus Drugs 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Dermatology (AREA)
- Botany (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110680523.5A CN113181240B (zh) | 2021-06-18 | 2021-06-18 | 构树根皮在制备治疗特应性皮炎的药物上的应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110680523.5A CN113181240B (zh) | 2021-06-18 | 2021-06-18 | 构树根皮在制备治疗特应性皮炎的药物上的应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN113181240A true CN113181240A (zh) | 2021-07-30 |
CN113181240B CN113181240B (zh) | 2022-04-01 |
Family
ID=76976576
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110680523.5A Active CN113181240B (zh) | 2021-06-18 | 2021-06-18 | 构树根皮在制备治疗特应性皮炎的药物上的应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113181240B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113842405A (zh) * | 2021-11-04 | 2021-12-28 | 广东药科大学 | 构树根皮提取物在制备皮肤抗敏止痒药物中的应用 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008071075A1 (fr) * | 2006-12-11 | 2008-06-19 | Yu Shi | Procédé de préparation d'extrait de broussonetia papyritera et utilisation de cet extrait dans la fabrication d'un médicament |
-
2021
- 2021-06-18 CN CN202110680523.5A patent/CN113181240B/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008071075A1 (fr) * | 2006-12-11 | 2008-06-19 | Yu Shi | Procédé de préparation d'extrait de broussonetia papyritera et utilisation de cet extrait dans la fabrication d'un médicament |
Non-Patent Citations (1)
Title |
---|
孙博强等: "DNCB诱导昆明小鼠特应性皮炎模型的建立", 《生物技市世界》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113842405A (zh) * | 2021-11-04 | 2021-12-28 | 广东药科大学 | 构树根皮提取物在制备皮肤抗敏止痒药物中的应用 |
CN113842405B (zh) * | 2021-11-04 | 2022-08-30 | 广东药科大学 | 构树根皮提取物在制备皮肤抗敏止痒药物中的应用 |
Also Published As
Publication number | Publication date |
---|---|
CN113181240B (zh) | 2022-04-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TWI501772B (zh) | 具抗關節炎活性的到手香精萃物 | |
TW200908990A (en) | Process for the preparation of plant extracts for treating skin disorders and enhancing healing of wounds | |
KR102526210B1 (ko) | 매스틱검 추출 발효물을 유효성분으로 포함하는 피부재생 또는 피부 상처 개선용 화장료 조성물 및 이의 제조방법 | |
WO2006076844A1 (fr) | Medicament chinois traditionnel destine a traiter les blessures resultant de chutes, rhumatisme et ostealgie et son procede de fabrication | |
CN108704021B (zh) | 用于皮肤过敏及皮肤屏障受损的组合物及制备方法 | |
JP7208892B2 (ja) | パープルコーン抽出物を含む皮膚疾患の予防または治療用薬剤学的組成物 | |
CN113181240B (zh) | 构树根皮在制备治疗特应性皮炎的药物上的应用 | |
US20140255526A1 (en) | Use of a ginseng extract to prevent and treat alopecia areata | |
KR100991399B1 (ko) | 어성초, 금전초, 차전초, 느릅나무 및 상엽 혼합추출물을유효 성분으로 함유하는 알레르기성 피부질환 예방 및치료용 약학적 조성물 | |
KR20090084435A (ko) | 어성초 및 느릅나무 혼합추출물을 유효 성분으로 함유하는알레르기성 피부질환 예방 및 치료용 약학적 조성물 | |
KR20030055154A (ko) | 피부질환 치료용 조성물 및 그 제조방법 | |
CN112521389B (zh) | 用于促进伤口愈合的药物及方法 | |
KR101679391B1 (ko) | 피뿌리풀 추출물 또는 그의 분획물을 포함하는 상처를 치료하기 위한 조성물 및 개체의 상처를 치료하는 방법 | |
CN114146051A (zh) | 生肌愈疡中药凝胶剂及其制备方法 | |
CN102973680B (zh) | 一种用于治疗浅部真菌感染的外用搽剂及其制备方法 | |
KR20150037204A (ko) | 대복피 추출물 포함 창상 치유용 조성물 | |
CN115869352B (zh) | 一种治疗雄激素性脱发的中药复方制剂及其制备方法与应用 | |
CN114748527B (zh) | 一种治疗婴幼儿湿疹、皮炎的复方龙胆凝胶 | |
CN102526266B (zh) | 一种治疗阴道炎的中药制剂及其制备方法 | |
CN111544564B (zh) | 一种婴儿尿布性皮炎药膏及其制备方法 | |
CN107714834A (zh) | 一种山茶油外用制剂的组合物、制备方法及其应用 | |
CN108635530B (zh) | 一种治疗银屑病的外用药物 | |
CN117085059A (zh) | 一种治疗银屑病的外用蒙药 | |
CN100387254C (zh) | 一种中药栓剂及其制备方法 | |
CN118319980A (zh) | 一种具有皮肤再生修复作用的乌药提取物凝胶及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240722 Address after: 572000, located 240 meters north of the intersection of No. 28 Road and Xindao Street in Yacheng Town, Yazhou District, Sanya City, Hainan Province, China. Merchants Sea Moon Garden Shop S2116-S2117, Deep Sea Science and Technology City Patentee after: Hainan Jiuxu Pharmaceutical Technology Co.,Ltd. Country or region after: China Address before: 510000 40 Haizhuqu District, Guangdong, Guangzhou. Patentee before: GUANGDONG PHARMACEUTICAL University Country or region before: China |